CXCL9 as a biomarker for disease activity in patients with morphea

被引：1
|
作者：
Florez-Pollack, S. [1 ]
O'Brien, J. C. [1 ]
Jacobe, H. T. [1 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Dermatol, Dallas, TX USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2018年 / 138卷 / 05期
关键词：
D O I：
10.1016/j.jid.2018.03.456
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
449
引用
收藏
页码：S76 / S76
页数：1
相关论文
共 50 条
  • [41] CXCL9 as a Reliable Biomarker for Discriminating Anti–IFN-γ-Autoantibody–Associated Lymphadenopathy that Mimics Lymphoma
    Chang-Tsu Yuan
    Wan-Ting Huang
    Chia-Lang Hsu
    Hsuan Wang
    Yi-Hua Pan
    Un-In Wu
    Jann-Tay Wang
    Wang-Huei Sheng
    Yee-Chun Chen
    Shan-Chwen Chang
    Journal of Clinical Immunology, 2024, 44
  • [42] Expression of CXCL9, -10, and -11 in the Aqueous Humor of Patients With Herpetic Endotheliitis
    Park, Jung-Won
    Li, Zhengri
    Choi, Ji-Suk
    Oh, Han-Jin
    Park, Soo-Hyun
    Yoon, Kyung-Chul
    CORNEA, 2012, 31 (11) : 1246 - 1250
  • [43] The chemokine CXCL9 expression is associated with better prognosis for colorectal carcinoma patients
    Wu, Zhenqian
    Huang, Xiuyan
    Han, Xiaodong
    Li, Zhongnan
    Zhu, Qinchao
    Yan, Jun
    Yu, Song
    Jin, Zhiming
    Wang, Zhigang
    Zheng, Qi
    Wang, Yu
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 78 : 8 - 13
  • [44] CXCL9 and CXCL10 are differentially associated with systemic organ involvement and pulmonary disease severity in sarcoidosis
    Arger, Nicholas K.
    Ho, Melissa E.
    Allen, Isabel E.
    Benn, Bryan S.
    Woodruff, Prescott G.
    Koth, Laura L.
    RESPIRATORY MEDICINE, 2020, 161
  • [45] CXCL9 expression and polyomavirus BK infectivity in renal transplant patients with nephropathy
    Kariminik, A.
    Yaghobi, R.
    Dabiri, S.
    CELLULAR AND MOLECULAR BIOLOGY, 2016, 62 (01) : 104 - 108
  • [46] Procalcitonin and CXCL9 As Potential Biomarkers for Pneumonia in Patients with Systemic Lupus Erythematosus
    Fragoso-Loyo, Hilda
    Hinojosa-Azaola, Andrea
    Rios-Corzo, Ricardo
    Hernandez-Flores, John
    Lopez-Lopez, Mariana
    Diaz-Mora, Ariadna
    Lilia Pulido-Ramirez, Alma
    Sifuentes-Osornio, Jose
    de Lourdes Guerrero-Almeida, Maria
    Alfredo Ponce de Leon-Garduno, Luis
    Carrillo-Maravilla, Eduardo
    Llorente, Luis
    Atisha-Fregoso, Yemil
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [47] The CXCL9 Polymorphism rs884304 Associates with Early CXCL9 Reconstitution and with Severe Chronic Graft-Versus-Host Disease (cGVHD) in Human Allograft Recipients
    Dai, Hao
    Rachakonda, Sivaramakrishna P.
    Penack, Olaf
    Radujkovic, Aleksandar
    Mueller-Tidow, Carsten
    Kumar, Rajiv
    Dreger, Peter
    Luft, Thomas
    BLOOD, 2019, 134
  • [48] Increased urinary levels of CXCL5, CXCL8 and CXCL9 in patients with Type 2 diabetic nephropathy
    Higurashi, Mayumi
    Ohya, Yoshiyuki
    Joh, Kensuke
    Muraguchi, Masahiro
    Nishimura, Motonobu
    Terawaki, Hiroyuki
    Yagui, Kazuo
    Hashimoto, Naotake
    Saito, Yasushi
    Yamada, Kenichi
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2009, 23 (03) : 178 - 184
  • [49] Increase of Interferon-γ Inducible CXCL9 and CXCL11 Serum Levels in Patients with Active Graves' Disease and Modulation by Methimazole Therapy
    Antonelli, Alessandro
    Ferrari, Silvia Martina
    Corrado, Alda
    Ferrannini, Ele
    Fallahi, Poupak
    THYROID, 2013, 23 (11) : 1461 - 1469
  • [50] Correlations of Type I Interferon Score and Interferon Induced Chemokines CXCL10 and CXCL9 with Cutaneous and Muscular Disease Activity in Juvenile Dermatomyositis
    Moneta, Gian Marco
    Caiello, Ivan
    Rava, Lucilla
    Rosina, Silvia
    Laudiero, Luisa Bracci
    Ravelli, Angelo
    De Benedetti, Fabrizio
    Nicolai, Rebecca
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
12345